Comparison

Methylnaltrexone bromide European Partner

Item no. TMO-T21422-100mg
Manufacturer TargetMol
CASRN 73232-52-7
Amount 100 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 99.88%
Citations Rauck RL. Treatment of opioid-induced constipation: focus on the peripheral u-opioid receptor antagonist methylnaltrexone. Drugs. 2013 Aug;73(12):1297-306. doi: 10.1007/s40265-013-0084-5. Review. PubMed PMID: 23881667.
Smiles O=C1[C@@](OC2=C(O)C=CC3=C24)([H])[C@@]54CC[N+](C)(CC6CC6)[C@@](C3)([H])[C@]5(O)CC1.[Br-]
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Relistor,MOA-728,MOA 728,Methylnaltrexone,MOA728
Shipping Condition Cool pack
Available
Manufacturer - Targets
Opioid Receptor
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
436.35
Description
Methylnaltrexone bromide (MOA-728) is one of the newer agents of peripherally-acting μ-opioid antagonists. Methylnaltrexone bromide acts to reverse some of the side effects of opioid drugs such as constipation without affecting analgesia or precipitating withdrawals.
Pathways
Neuroscience|||GPCR/G Protein|||Endocrinology/Hormones

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close